Table 2.
Effect of doxycycline treatment on presence of Wolbachia in worms: results of immunohistology
| Treatment group | Time (months) | Number of patients/nodules | Number of living female worms | Number of living male worms | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| All | With Wolbachia | Alla | With Wolbachia | |||||||
| Many | Few | None | Many | Few | None | |||||
| Placebo | 6 | 13/14 | 29 | 26 | 0 | 3 | 8 | 7 | 1 | 0 |
| 20 | 16/51 | 70 | 58 | 7 | 5 | 25 | 18 | 2 | 3 | |
| 27 | 7/38 | 61 | 50 | 9 | 2 | 25 | 14 | 3 | 5 | |
| Doxycycline (4 weeks) | 20 | 7/36 | 27 | 3 | 4 | 20b | 21 | 3 | 2 | 16b |
| 27 | 7/23 | 20 | 4 | 2 | 14b | 9 | 6 | 2 | 1 | |
| Doxycycline (6 weeks) | 6 | 11/19 | 32 | 1 | 8 | 23b | 18 | 1 | 2 | 14b |
| 20 | 13/62 | 42 | 9 | 033 | 33b,d | 20 | 3 | 2 | 15b | |
| 27 | 5/27 | 15 | 5 | 0 | 10b | 14 | 2 | 0 | 11c,e | |
aWhile the number of all living worms is given to make the numbers consistent to the other tables, in some instances it was not possible to distinguish if a male worm had many, few or no Wolbachia, due to too little worm material in the respective histological sections. Therefore, “All” is not always a summary of the three categories for males
b,cSignificant difference between the respective doxycycline and the placebo group regarding the distribution between many, few and no Wolbachia at the respective time points (bP < 0.0001; cP < 0.002, Chi-square test)
d,eSignificant difference between the two doxycycline groups regarding the distribution between many, few and no Wolbachia at the respective time points (dP = 0.03; eP = 0.003, Chi-square test)